N4-Acetylcytidine
| Names | |
|---|---|
| IUPAC name
N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
| |
Other names
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.021.087 |
| EC Number |
|
| KEGG | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C11H15N3O6 | |
| Molar mass | 285.256 g·mol−1 |
| Appearance | white amorphous solid, sometimes yellow/brown |
| Density | 1.72 g/cm3 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
N4-Acetylcytidine (ac4C, ac4C) is a post-transcriptional modification found in tRNAs, rRNAs, and mRNAs. In this modification, the amino group at the N4 position of the RNA base cytosine is acetylated, resulting in the formation of an amide. In vivo, this modification is considered highly conserved because it is seen in all three domains of life: archaea, bacteria, and eukarya.